November 24, 2025
SANTA CLARA, Calif. — November 25, 2025 — Leads & Copy — Agilent Technologies, Inc. (NYSE: A) announced its fourth-quarter revenue for the period ending October 31, 2025, reached $1.86 billion, surpassing expectations. This represents a 9.4% increase as reported, and a 7.2% increase in core revenue compared to the same quarter last year.
GAAP net income for the fourth quarter was $434 million, or $1.53 per share, compared to $351 million, or $1.22 per share, in the fourth quarter of 2024. Non-GAAP net income for the quarter was $452 million, or $1.59 per share, compared to $418 million, or $1.46 per share, in the same period last year.
Padraig McDonnell, Agilent President and CEO, expressed confidence in the company’s future, stating that Agilent is uniquely positioned to lead in life sciences and diagnostics. He attributed the company’s progress to innovation, a customer-focused approach, and the expansion of their Ignite Operating System.
In the first quarter of 2025, Agilent implemented certain changes to its segment reporting structure. Prior-period segment information has been recast to reflect these changes. These changes have no impact on Agilent’s consolidated financial statements.
The Life Sciences and Diagnostics Markets Group (LDG) reported fourth-quarter revenue of $755 million, a 15% increase as reported and an 11% core increase year-over-year. The operating margin for LDG was 22.7% for the quarter.
The Agilent CrossLab Group (ACG) reported fourth-quarter revenue of $755 million, reflecting a 7% increase as reported and a 6% core increase year-over-year. ACG’s operating margin for the quarter was 32.5%.
The Applied Markets Group (AMG) reported fourth-quarter revenue of $351 million, a 4% increase as reported and a 3% core increase year-over-year. AMG’s operating margin for the quarter was 24.7%.
Agilent’s outlook for the full year 2026 projects revenue between $7.3 billion and $7.4 billion, indicating growth of 5% to 7% as reported and 4% to 6% core. Non-GAAP EPS is projected to be in the range of $5.86 to $6.00 per share.
For the first quarter of 2026, revenue is expected to be between $1.79 billion and $1.82 billion, representing a growth of 6% to 8% as reported and 4% to 6% core. Non-GAAP EPS is expected to be in the range of $1.35 to $1.38 per share.
Agilent’s management hosted a conference call to discuss these results. A replay of the call will be available on the company’s Investor Relations website for 90 days.
Agilent Technologies, Inc. is a global leader in analytical and clinical laboratory technologies. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.
The company’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions.
Agilent Technologies, Inc. is traded on the New York Stock Exchange under the ticker symbol A.
Forward-Looking Statements
This release contains forward-looking statements regarding Agilent’s growth prospects, business, financial results, revenue, non-GAAP earnings guidance for Q1 and fiscal year 2026, and the effects of its new organizational structure, operational transformation and market-focused strategy. Actual results could differ materially due to various risks and uncertainties, including customer demand, currency market fluctuations, and the company’s ability to realize expected savings. Agilent does not undertake any responsibility to update or revise these statements.
(1) Core revenue growth excludes the impact of currency and acquisitions and divestitures within the past 12 months. Core revenue is a non-GAAP measure. Reconciliations between GAAP revenue and core revenue for Q4 fiscal year 2025 and full fiscal year 2025 are set forth on page 6 and 7 of the attached tables along with additional information regarding the use of this non-GAAP measure. Core revenue growth rate as projected for Q1 fiscal year 2026 and full fiscal year 2026 excludes the impact of currency and acquisitions and divestitures within the past 12 months. Most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided for the projection.
For further information, please contact:
Source: Agilent Technologies, Inc.
